Interview w/ Adrienne Godschalx re: Plant Defenses, Confirming Einstein, Void Life, We're All Moroccan?, Old Rock... Paintings, CAR-T Therapy Win, Monkey Cat!!!, Climate's All Connected, Magic Of Mucus, And Much More...
NYS Entity Status
NYS Filing Date
FEBRUARY 15, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2013 - ADRIENNE W. KATZOW, PHD, CLINICAL PSYCHOLOGIST PLLC
AROUND THE WEB
- 07 June, 2017 – Episode 622 – This Week in Science Podcast (TWIS)
By Kirsten Sanford - Friday Jun 9, 2017
- Conviction Overturned for ex-NY Assembly Speaker Sheldon Silver
Thursday Jul 13, 2017
A federal appeals court has overturned the corruption conviction of former New York Assembly Speaker Sheldon Silver.
- Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
By Frank Vinluan - Wednesday Jun 14, 2017
The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]
- Patient denied appointment at pain clinic shoots 2 employees, kills himself
By Associated Press - Friday Jun 30, 2017
LAS VEGAS — A patient denied a same-day appointment at a pain-management clinic in Las Vegas shot and injured two employees Thursday before fatally shooting himself, police said. As other patients and staff fled, the man, who was a regular patient at the Center for Wellness and Pain Care, turned the gun on himself, police...
- New York City and James Blake Resolve Excessive-Force Claim
By BENJAMIN MUELLER - Wednesday Jun 21, 2017
As part of the deal with the former pro tennis player, the city will create a new position within the agency that investigates police misconduct.
- FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths
By Frank Vinluan - Wednesday Jul 5, 2017
Nearly a month after Merck paused enrollment in three clinical trials in multiple myeloma to gather more information about patient deaths, the FDA has now put a stop to those studies altogether. Merck (NYSE: MRK) said Wednesday that the FDA has placed a complete hold on two Phase 3 trials testing its immunotherapy drug pembrolizumab […]